Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Neuronal nicotinic receptor ligands profiled at AstraZeneca

Nov. 24, 2008

Merck Eprova imparts new PET imaging agents in recent patents

Nov. 17, 2008

Ensemble and Roche extend collaboration for diagnostic technology in cancer therapy

Nov. 13, 2008

New diagnostic agents imparted by Merck Eprova

Nov. 13, 2008

Nanogen and Menarini sign agreement to commercialize IVD infectious disease kits

Nov. 10, 2008

Eisai reviews H1 pipeline progression

Nov. 10, 2008

Celera and Abbott collaborate to identify pharmacogenomic markers

Nov. 6, 2008

Neoprobe receives positive EMEA response to RIGScan CR submission

Nov. 4, 2008

FDA approves donated blood screening test for HIV, HCV and HBV

Nov. 4, 2008

AstraZeneca develops 5-HT1B receptor radioligand for PET imaging

Nov. 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...